Bill Gates-backed Ginkgo Bioworks going public via $15 billion SPAC
Published
May 11 2021 at 2:04 PM GMT
Key
Points
Points
- Ginkgo Bioworks is going public via a merger with former MGM CEO Harry Sloan's SPAC in a deal that values the biotech company at $15 billion.
Tags
-
Posted in Top Stories
Trending
Stats
- Published May 11, 2021 2:04 PM GMT